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ABSTRACT 
 
Cancer management is associated with serious side-effects due to the harmful nature of 
radiation and chemotherapy on the body cells. These side-effects have necessitated the 
need for diversifying the alternative or complementary sources of cancer therapy. Natural 
products have been on the front line as alternative sources of anticancer agents and have 
attracted much attention in recent times. In this study, the anticancer activity of Hypsizygus 
tessellatus (white var.) caps (also known as Bunapi shimeji) extracted with acetone and ethyl 
acetate was evaluated in vitro against MDA-MB-231 and MCF-7 (breast cancer cell lines) and 
MCF-10a (Vero or normal breast cells). Likewise, the free radical scavenging and metal 
reducing activities of the extract were evaluated through in vitro chemical-based methods. 
Furthermore, the phytochemical compositions of the extracts were determined through LC–
MS-QTOF-assisted mass spectroscopy. The results of this study indicated that acetone 
fraction had better radical scavenging activity against DPPH (IC50 = 0.76 mg/mL) and 
H2O2(IC50 = 0.84 mg/mL) than ethyl acetate fraction against DPPH (IC50 = 1.10 mg/mL) and 
H2O2 (IC50 = 1.26 mg/mL) (p < 0.05). Additionally, the acetone fraction was observed to 
have more antiproliferative effects against MCF-7 (IC50 = 0.051–0.055 mg/mL) and MDAMB- 
231 (IC50 = 0.122–0.131 mg/mL) compared to the ethyl acetate fraction against MCF-7 (IC50 = 
0.075–0.096 mg/mL) and MDA-MB-231 (IC50 = 0.161–0.164 mg/mL) (p < 0.05). Both extracts 
generally had less effect on MCF-10a cells. Thus, these results suggested that Bunapi shimeji 
caps is a potential good natural source of anticancer agents. 
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